Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]

Detalles Bibliográficos
Autores principales: Jiang, Chao, Liu, Xueyan, Wang, Meng, Lv, Guoyue, Wang, Guangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2021
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420907/
https://www.ncbi.nlm.nih.gov/pubmed/34503610
http://dx.doi.org/10.3727/096504018X16233193839045
_version_ 1783748973053345792
author Jiang, Chao
Liu, Xueyan
Wang, Meng
Lv, Guoyue
Wang, Guangyi
author_facet Jiang, Chao
Liu, Xueyan
Wang, Meng
Lv, Guoyue
Wang, Guangyi
author_sort Jiang, Chao
collection PubMed
description
format Online
Article
Text
id pubmed-8420907
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cognizant Communication Corporation
record_format MEDLINE/PubMed
spelling pubmed-84209072021-09-11 Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034] Jiang, Chao Liu, Xueyan Wang, Meng Lv, Guoyue Wang, Guangyi Oncol Res Retraction Cognizant Communication Corporation 2021-09-07 /pmc/articles/PMC8420907/ /pubmed/34503610 http://dx.doi.org/10.3727/096504018X16233193839045 Text en Copyright © 2021 Cognizant, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial NoDerivatives 4.0 International License.
spellingShingle Retraction
Jiang, Chao
Liu, Xueyan
Wang, Meng
Lv, Guoyue
Wang, Guangyi
Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
title Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
title_full Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
title_fullStr Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
title_full_unstemmed Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
title_short Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
title_sort retraction notice to “high blood mir-802 is associated with poor prognosis in hcc patients by regulating dna damage response 1 (redd 1)-mediated function of t cells” [oncology research 27(9) (2019) 1025-1034]
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420907/
https://www.ncbi.nlm.nih.gov/pubmed/34503610
http://dx.doi.org/10.3727/096504018X16233193839045
work_keys_str_mv AT jiangchao retractionnoticetohighbloodmir802isassociatedwithpoorprognosisinhccpatientsbyregulatingdnadamageresponse1redd1mediatedfunctionoftcellsoncologyresearch279201910251034
AT liuxueyan retractionnoticetohighbloodmir802isassociatedwithpoorprognosisinhccpatientsbyregulatingdnadamageresponse1redd1mediatedfunctionoftcellsoncologyresearch279201910251034
AT wangmeng retractionnoticetohighbloodmir802isassociatedwithpoorprognosisinhccpatientsbyregulatingdnadamageresponse1redd1mediatedfunctionoftcellsoncologyresearch279201910251034
AT lvguoyue retractionnoticetohighbloodmir802isassociatedwithpoorprognosisinhccpatientsbyregulatingdnadamageresponse1redd1mediatedfunctionoftcellsoncologyresearch279201910251034
AT wangguangyi retractionnoticetohighbloodmir802isassociatedwithpoorprognosisinhccpatientsbyregulatingdnadamageresponse1redd1mediatedfunctionoftcellsoncologyresearch279201910251034

Ejemplares similares